DK131868C - Analogifremgangsmade til fremstilling af tri-p-toluensulfonatet af s-adenosyl-l-methionin - Google Patents

Analogifremgangsmade til fremstilling af tri-p-toluensulfonatet af s-adenosyl-l-methionin

Info

Publication number
DK131868C
DK131868C DK422773A DK422773A DK131868C DK 131868 C DK131868 C DK 131868C DK 422773 A DK422773 A DK 422773A DK 422773 A DK422773 A DK 422773A DK 131868 C DK131868 C DK 131868C
Authority
DK
Denmark
Prior art keywords
adenosyl
methionine
tri
preparation
toluene sulphonate
Prior art date
Application number
DK422773A
Other languages
Danish (da)
English (en)
Other versions
DK131868B (da
Inventor
A Fiecchi
Original Assignee
Bioresearch Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Sas filed Critical Bioresearch Sas
Publication of DK131868B publication Critical patent/DK131868B/da
Application granted granted Critical
Publication of DK131868C publication Critical patent/DK131868C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK422773A 1972-08-02 1973-08-01 Analogifremgangsmade til fremstilling af tri-p-toluensulfonatet af s-adenosyl-l-methionin DK131868C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (2)

Publication Number Publication Date
DK131868B DK131868B (da) 1975-09-15
DK131868C true DK131868C (da) 1976-03-08

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK422773A DK131868C (da) 1972-08-02 1973-08-01 Analogifremgangsmade til fremstilling af tri-p-toluensulfonatet af s-adenosyl-l-methionin

Country Status (29)

Country Link
US (1) US3893999A (ro)
JP (1) JPS5235726B2 (ro)
AR (1) AR195350A1 (ro)
AT (1) AT341684B (ro)
AU (1) AU474015B2 (ro)
BE (1) BE802981A (ro)
CA (1) CA1006872A (ro)
CH (1) CH592112A5 (ro)
CS (1) CS195254B2 (ro)
DD (1) DD107461A5 (ro)
DE (1) DE2336401C3 (ro)
DK (1) DK131868C (ro)
ES (1) ES417377A1 (ro)
FI (1) FI52466C (ro)
FR (1) FR2194425B1 (ro)
GB (1) GB1425384A (ro)
HK (1) HK31580A (ro)
HU (1) HU167266B (ro)
IE (1) IE37913B1 (ro)
IL (1) IL42764A (ro)
MX (1) MX4544E (ro)
NL (1) NL152864B (ro)
NO (1) NO137941C (ro)
PL (1) PL87381B1 (ro)
RO (1) RO63451A (ro)
SE (1) SE400085B (ro)
SU (1) SU646915A3 (ro)
YU (1) YU36037B (ro)
ZA (1) ZA734876B (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
AU2538588A (en) * 1987-10-09 1989-05-02 Mario De Rosa Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
US8063024B2 (en) * 2005-01-26 2011-11-22 University Of Manitoba Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20080206333A1 (en) * 2007-01-31 2008-08-28 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20140187509A1 (en) * 2011-04-15 2014-07-03 Scimar Ltd. Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
IN2015DN04151A (ro) 2012-10-17 2015-10-16 Methylation Sciences Internat Srl
ES2824807T3 (es) 2013-01-16 2021-05-13 Hebert Sam E Llc Sales de indol-3-propionato estables de S-adenosil-L-metionina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
SU646915A3 (ru) 1979-02-05
US3893999A (en) 1975-07-08
PL87381B1 (ro) 1976-06-30
IL42764A0 (en) 1974-01-14
NL152864B (nl) 1977-04-15
AT341684B (de) 1978-02-27
DD107461A5 (ro) 1974-08-05
JPS4992215A (ro) 1974-09-03
JPS5235726B2 (ro) 1977-09-10
SE400085B (sv) 1978-03-13
GB1425384A (en) 1976-02-18
DE2336401B2 (de) 1979-07-12
DK131868B (da) 1975-09-15
DE2336401A1 (de) 1974-02-14
IE37913B1 (en) 1977-11-09
YU36037B (en) 1981-11-13
ES417377A1 (es) 1976-02-16
NO137941C (no) 1978-05-31
CS195254B2 (en) 1980-01-31
ZA734876B (en) 1974-06-26
IL42764A (en) 1976-04-30
BE802981A (fr) 1973-11-16
NO137941B (no) 1978-02-13
HU167266B (ro) 1975-09-27
FR2194425B1 (ro) 1976-04-09
AU474015B2 (en) 1976-07-08
FI52466B (ro) 1977-05-31
FR2194425A1 (ro) 1974-03-01
RO63451A (fr) 1978-07-15
HK31580A (en) 1980-06-20
AR195350A1 (es) 1973-09-28
FI52466C (fi) 1977-09-12
CH592112A5 (ro) 1977-10-14
YU203073A (en) 1981-04-30
NL7310706A (ro) 1974-02-05
DE2336401C3 (de) 1980-03-13
MX4544E (es) 1982-06-08
ATA664173A (de) 1977-06-15
AU5868073A (en) 1975-01-30
IE37913L (en) 1974-02-02
CA1006872A (en) 1977-03-15

Similar Documents

Publication Publication Date Title
DK131868C (da) Analogifremgangsmade til fremstilling af tri-p-toluensulfonatet af s-adenosyl-l-methionin
DK152050C (da) Analogifremgangsmaade til fremstilling af oxazolopyridiner
DK134177C (da) Fremgangsmade til fremstilling af 3-(piperazinoalkyl)-pyrazoler
DK135684C (da) Analogifremgangsmade til fremstilling af dibenzofuranderivater
DK133741B (da) Analogifremgangsmade til fremstilling af indankarboxamidderivater
DK139966C (da) Fremgangsmaade til fremstilling af 1-hydroxy-2-pyridoner
DK136062C (da) Fremgangsmade til fremstilling af 2-alkylamino-dihydropyridiner
DK133279B (da) Analogifremgangsmade til fremstilling af phenylaminoethanolderivater
DK139751B (da) Analogifremgangsmaade til fremstilling af n-benzhydryl-n!-p-hydroxybenzyl-piperaziner
DK134782C (da) Fremgangsmade til fremstilling af 3beta-hydroxy-5beta-h-steroider
DK131855C (da) Fremgangsmade til fremstilling af 3,4-dihydropyridoner
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK139270C (da) Fremgangsmaade til fremstilling af alfa-kobberphthalocyanin
DK238090D0 (da) Fremgangsmaade til fremstilling af benzocycloheptathiophenderivater
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
DK132410C (da) Analogifremgangsmade til fremstilling af 2-amino-4h-pyraner
DK131734C (da) Fremgangsmade til fremstilling af en isomeriseret humleekstrakt
DK133468B (da) Analogifremgangsmade til fremstilling af 1-benzyl-3-amino-pyrazoloner-(5)
DK132832C (da) Analogifremgangsmade til fremstilling af alfa-acyldigitoxiner
DK132283C (da) Analogifremgangsmade til fremstilling af 15-oxasteroider
DK144872C (da) Fremgangsmaade til fremstilling af pyrazolonholdige tabletter
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK133777C (da) Fremgangsmade til fremstilling af alfa-oximinonitriler
DK133240C (da) Analogifremgangsmade til fremstilling af cyklopentylaminobutanolderivater
DK134398C (da) Analogifremgangsmade til fremstilling af amidophenylisothiourinstoffer

Legal Events

Date Code Title Description
PUP Patent expired